Ms. Shannon Karl reports

TECSYS ANNOUNCES RENEWAL OF ITS NORMAL COURSE ISSUER BID

The Toronto Stock Exchange has approved the renewal of TECSYS Inc.'s normal course issuer bid (NCIB).

TECSYS believes that the market value of its common shares may not always fully reflect the full value of the company and, in such circumstances, purchases under the NCIB may represent an appropriate and desirable use of its available funds. Such purchases will increase the proportional share interest of those shareholders who retain their shares. Any purchases made by TECSYS under the NCIB will be made by TECSYS at the prevailing market price at the time of acquisition, plus brokerage fees, through the facilities of the TSX and other designated exchanges and/or alternative Canadian trading systems.

Pursuant to the NCIB, during the 12-month period commencing Oct. 2, 2026, and ending Oct. 1, 2027, TECSYS intends to purchase up to 900,000 shares, which represents 9.2 per cent of the company's public float as of Sept. 21, 2026. As of that date, the company had 14,416,937 shares issued and outstanding, of which 9,754,906 common shares constituted the public float. Under the NCIB, other than purchases made under block purchase exemptions, TECSYS may purchase up to 2,789 shares on the TSX during any trading day, which represents 25 per cent of 11,157, being the average daily trading volume for the six months ended Aug. 31, 2026, excluding shares purchased under the NCIB during that time. Any shares purchased under the NCIB will be cancelled.

Share repurchases made pursuant to the company's NCIB will be predicated upon maintaining a strong balance sheet, performance of the business, and the availability and attractiveness of alternative capital investment opportunities. The actual number of shares purchased under the NCIB, the timing of the purchases, and the price at which the shares are acquired will depend upon a variety of factors, including future market conditions.

TECSYS has established an automatic securities purchase plan with a designated broker, which will allow for the purchase for cancellation of shares under the NCIB, subject to certain trading parameters, by its designated broker during times when TECSYS would ordinarily not be active in the market due to applicable regulatory restrictions or self-imposed blackout periods. Outside of these periods, the shares will be repurchased by TECSYS at its discretion under the NCIB.

Under its prior normal course issuer bid, which commenced on Sept. 20, 2025, and ended Sept. 19, 2026, the company sought and received approval from the TSX to purchase up to 900,000 common shares, as amended effective March 19, 2026. The company purchased 388,400 common shares under the prior NCIB at a weighted average price of $30.20 per common share through the facilities of the TSX and other designated exchanges and/or alternative Canadian trading systems.

About TECSYS Inc.

TECSYS is trusted by mission-critical organizations in health care and distribution to build resilient, efficient and secure supply chains. A global provider of cloud-based, AI-driven (artificial intelligence) software with deep domain expertise, TECSYS delivers real-time operational visibility and execution across critical workflows when performance and reliability matter most. TECSYS is publicly traded on the TSX (symbol: TCS).

We seek Safe Harbor.